UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences

Williams Ettouati
Director of Industrial Relations and Development 

Upsher-Smith Laboratories, Inc. United States

Upsher-Smith Laboratories, Inc. is pursuing improved drug therapies to improve people’s lives.  The evolution of their company is driven by the ever-changing needs of patients, physicians, pharmacists, and healthcare organizations.  Their perspective is not “more products,” but the right products that make people’s lives better.  At every level of their business, they are driven to be the best.

 

Upsher-Smith is actively pursuing product development opportunities in the therapeutic areas of epilepsy and Parkinson’s disease; their current product portfolio is focused in the areas of women’s health, dermatology, and cardiology.   

With a track record of successful collaboration in licensing and acquiring innovative products, Upsher-Smith is a trusted partner to many leading pharmaceutical companies, offering expertise in:   

 

  • Conducting clinical trials to support safety and efficacy
  • Preparing and managing submissions for the FDA review process
  • Commercialization and distribution of products to the retail and wholesale trade
  • Marketing and sales promotions through sales force, national conventions, professional advertising, and other media 

As an independent and privately held company, Upsher-Smith acts swiftly to create the right partnerships and connections that build upon their success.

 

On August 14, 2012, the company completed its acquisition of UK-based Proximagen Group plc, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation. 

 

Upsher-Smith also has offices in Plymouth, MN, Denver, CO and Morristown, NJ.

 

“Advancing pharmacotherapy.  Improving lifeSM”….  As the company evolves, Upsher-Smith’s goal remains the same:  to assist individuals in making the best use of medicines.  This not only means producing quality pharmaceutical products, but providing access to them as well.  The company promises to provide reliable, affordable products that have a daily impact to improve lives.

 

Upsher-Smith’s vision is to become a leader in providing therapies that empower people suffering from central nervous system (CNS) diseases to lead healthy, productive lives.

Business Type
Ms Lori Freese
Director, Strategic Portfolio Management 
Mr Mike McBride
Sr. Director, Industry Relations